174 related articles for article (PubMed ID: 19822838)
21. Urinary metabolites of prostanoids and risk of recurrent colorectal adenomas in the Aspirin/Folate Polyp Prevention Study (AFPPS).
Fedirko V; Bradshaw PT; Figueiredo JC; Sandler RS; Barry EL; Ahnen DJ; Milne GL; Bresalier RS; Baron JA
Cancer Prev Res (Phila); 2015 Nov; 8(11):1061-8. PubMed ID: 26304466
[TBL] [Abstract][Full Text] [Related]
22. Plasma lipoxin A
Fedirko V; McKeown-Eyssen G; Serhan CN; Barry EL; Sandler RS; Figueiredo JC; Ahnen DJ; Bresalier RS; Robertson DJ; Anderson CW; Baron JA
Mol Carcinog; 2017 Aug; 56(8):1977-1983. PubMed ID: 28218420
[TBL] [Abstract][Full Text] [Related]
23. Folic acid mediated attenuation of loss of heterozygosity of DCC tumor suppressor gene in the colonic mucosa of patients with colorectal adenomas.
Nagothu KK; Jaszewski R; Moragoda L; Rishi AK; Finkenauer R; Tobi M; Naumoff JA; Dhar R; Ehrinpreis M; Kucuk O; Majumdar AP
Cancer Detect Prev; 2003; 27(4):297-304. PubMed ID: 12893078
[TBL] [Abstract][Full Text] [Related]
24. Non-steroidal anti-inflammatory drug use is associated with reduction in recurrence of advanced and non-advanced colorectal adenomas (United States).
Tangrea JA; Albert PS; Lanza E; Woodson K; Corle D; Hasson M; Burt R; Caan B; Paskett E; Iber F; Kikendall JW; Lance P; Shike M; Weissfeld J; Schatzkin A;
Cancer Causes Control; 2003 Jun; 14(5):403-11. PubMed ID: 12946034
[TBL] [Abstract][Full Text] [Related]
25. Ornithine decarboxylase polymorphism modification of response to aspirin treatment for colorectal adenoma prevention.
Barry EL; Baron JA; Bhat S; Grau MV; Burke CA; Sandler RS; Ahnen DJ; Haile RW; O'Brien TG
J Natl Cancer Inst; 2006 Oct; 98(20):1494-500. PubMed ID: 17047198
[TBL] [Abstract][Full Text] [Related]
26. Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial.
Benamouzig R; Uzzan B; Deyra J; Martin A; Girard B; Little J; Chaussade S;
Gut; 2012 Feb; 61(2):255-61. PubMed ID: 21890814
[TBL] [Abstract][Full Text] [Related]
27. A prospective study of aspirin use and the risk for colorectal adenoma.
Chan AT; Giovannucci EL; Schernhammer ES; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
Ann Intern Med; 2004 Feb; 140(3):157-66. PubMed ID: 14757613
[TBL] [Abstract][Full Text] [Related]
28. Summaries for patients. Relationships between aspirin dose and colorectal adenomas.
Ann Intern Med; 2004 Feb; 140(3):I24. PubMed ID: 14757630
[No Abstract] [Full Text] [Related]
29. Aspirin may be more effective in preventing colorectal adenomas in patients with higher BMI (United States).
Kim S; Baron JA; Mott LA; Burke CA; Church TR; McKeown-Eyssen GE; Cole BF; Haile RW; Sandler RS
Cancer Causes Control; 2006 Dec; 17(10):1299-304. PubMed ID: 17111262
[TBL] [Abstract][Full Text] [Related]
30. APACC, a French prospective study on aspirin efficacy in reducing colorectal adenoma recurrence: design and baseline findings.
Benamouzig R; Yoon H; Little J; Martin A; Couturier D; Deyra J; Coste T; Chaussade S;
Eur J Cancer Prev; 2001 Aug; 10(4):327-35. PubMed ID: 11535875
[TBL] [Abstract][Full Text] [Related]
31. The influence of UGT1A6 variants and aspirin use in a randomized trial of celecoxib for prevention of colorectal adenoma.
Chan AT; Hsu M; Zauber AG; Hawk ET; Bertagnolli MM
Cancer Prev Res (Phila); 2012 Jan; 5(1):61-72. PubMed ID: 22030088
[TBL] [Abstract][Full Text] [Related]
32. Effects of Folic Acid Supplementation on Inflammatory Markers: A Grade-Assessed Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials.
Asbaghi O; Ashtary-Larky D; Bagheri R; Moosavian SP; Nazarian B; Afrisham R; Kelishadi MR; Wong A; Dutheil F; Suzuki K; Alavi Naeini A
Nutrients; 2021 Jul; 13(7):. PubMed ID: 34371837
[TBL] [Abstract][Full Text] [Related]
33. Celecoxib for the prevention of colorectal adenomatous polyps.
Arber N; Eagle CJ; Spicak J; Rácz I; Dite P; Hajer J; Zavoral M; Lechuga MJ; Gerletti P; Tang J; Rosenstein RB; Macdonald K; Bhadra P; Fowler R; Wittes J; Zauber AG; Solomon SD; Levin B;
N Engl J Med; 2006 Aug; 355(9):885-95. PubMed ID: 16943401
[TBL] [Abstract][Full Text] [Related]
34. Aspirin and nonsteroidal anti-inflammatory agents and risk for colorectal adenomas.
Sandler RS; Galanko JC; Murray SC; Helm JF; Woosley JT
Gastroenterology; 1998 Mar; 114(3):441-7. PubMed ID: 9496933
[TBL] [Abstract][Full Text] [Related]
35. A randomized trial of aspirin to prevent colorectal adenomas.
Baron JA; Cole BF; Sandler RS; Haile RW; Ahnen D; Bresalier R; McKeown-Eyssen G; Summers RW; Rothstein R; Burke CA; Snover DC; Church TR; Allen JI; Beach M; Beck GJ; Bond JH; Byers T; Greenberg ER; Mandel JS; Marcon N; Mott LA; Pearson L; Saibil F; van Stolk RU
N Engl J Med; 2003 Mar; 348(10):891-9. PubMed ID: 12621133
[TBL] [Abstract][Full Text] [Related]
36. [Chemopreventive agents in colorectal cancer].
Benamouzig R; Chaussade S
Rev Prat; 2003 Dec; 53(20):2213-4. PubMed ID: 15018072
[No Abstract] [Full Text] [Related]
37. Aspirin and other nonsteroidal anti-inflammatory agents in the prevention of colorectal cancer.
Sandler RS
Important Adv Oncol; 1996; ():123-37. PubMed ID: 8791132
[TBL] [Abstract][Full Text] [Related]
38. Daily soluble aspirin and prevention of colorectal adenoma recurrence: one-year results of the APACC trial.
Benamouzig R; Deyra J; Martin A; Girard B; Jullian E; Piednoir B; Couturier D; Coste T; Little J; Chaussade S
Gastroenterology; 2003 Aug; 125(2):328-36. PubMed ID: 12891533
[TBL] [Abstract][Full Text] [Related]
39. Folic acid prevents the initial occurrence of sporadic colorectal adenoma in Chinese older than 50 years of age: a randomized clinical trial.
Gao QY; Chen HM; Chen YX; Wang YC; Wang ZH; Tang JT; Ge ZZ; Chen XY; Sheng JQ; Fang DC; Yu CG; Zheng P; Fang JY
Cancer Prev Res (Phila); 2013 Jul; 6(7):744-52. PubMed ID: 23682073
[TBL] [Abstract][Full Text] [Related]
40. Celecoxib for the prevention of sporadic colorectal adenomas.
Bertagnolli MM; Eagle CJ; Zauber AG; Redston M; Solomon SD; Kim K; Tang J; Rosenstein RB; Wittes J; Corle D; Hess TM; Woloj GM; Boisserie F; Anderson WF; Viner JL; Bagheri D; Burn J; Chung DC; Dewar T; Foley TR; Hoffman N; Macrae F; Pruitt RE; Saltzman JR; Salzberg B; Sylwestrowicz T; Gordon GB; Hawk ET;
N Engl J Med; 2006 Aug; 355(9):873-84. PubMed ID: 16943400
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]